Internal Medicine, Endocrinology, Diabetes, & Metabolism · Pittsburgh, PA
NPI
1073599445
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
363 Vanadium Rd Ste 102
Pittsburgh, PA, 15243
Phone (412) 221-4740
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
498 services
Medicare patients, 2024
144
Average age 73
Drug cost, 2024
$3.5M
10,392 prescriptions
Company payments, 2025
$67K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Swarna Varma was code 99214 (office e&m - established), 284 times for 136 patients. In total Swarna Varma billed 498 services in 6 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 284 | 136 | $81.96 | $23K |
| 99491 Chronic, Principal, and Transitional Care Management | Office | 171 | 97 | $61.90 | $11K |
| 99205 Office E&M - New | Office | 15 | 15 | $166.81 | $2,502 |
By year: 2022 $29K for 355 services; 2023 $27K for 338 services; 2024 $37K for 498 services.
Medicare prescription drug claims, 2024
In 2024, the drug Swarna Varma prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 1,268 prescriptions and refills. In total Swarna Varma wrote 10,392 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 1,268 | 1,506 | 189 | $1.5M |
| Repaglinide Generic | 946 | 1,932 | 254 | $47K |
| Atorvastatin Calcium Generic | 508 | 1,296 | 132 | $4,612 |
| Synthroid Levothyroxine Sodium | 495 | 1,125 | 109 | $47K |
| Rosuvastatin Calcium Generic | 458 | 1,031 | 124 | $7,063 |
| Valsartan Generic | 409 | 909 | 102 | $10K |
| Metformin Hcl Er Metformin Hcl | 394 | 914 | 109 | $5,970 |
| Amlodipine Besylate Generic | 391 | 979 | 104 | $1,954 |
| Unithroid Levothyroxine Sodium | 385 | 830 | 101 | $9,083 |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 324 | 741 | 97 | $206K |
| Icosapent Ethyl Generic | 270 | 514 | 78 | $90K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 245 | 536 | 100 | $30K |
| Ozempic Semaglutide | 231 | 313 | 43 | $287K |
| Humalog Kwikpen U-100 Insulin Lispro | 226 | 418 | 78 | $62K |
| Levoxyl Levothyroxine Sodium | 223 | 469 | 56 | $7,564 |
Brand drugs: 4,676 claims; generic drugs: 5,222 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Swarna Varma $67K ($67K in general payments such as food, travel and fees) from 15 companies. The largest payer was Lilly USA, LLC with $43K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 64 | $43K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 38 | $23K |
| Medtronic, Inc. MDT | 4 | $298 |
| Amneal Pharmaceuticals LLC AMRX | 12 | $237 |
| Abbvie Inc. ABBV | 9 | $166 |
| Amgen Inc. AMGN | 4 | $80.3 |
| Ascendis Pharma Endocrinology Inc ASND | 4 | $78.14 |
| Novo Nordisk Inc NVO | 4 | $70.96 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $51.37 |
| Madrigal Pharmaceuticals MDGL | 1 | $31.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.